---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-104917"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-10-31T23:59:59+00:00"
generated_at: "2026-05-17T01:06:48.631220+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nasdaq confirms Entero Therapeutics regains compliance with equity rule

## Summary
- Nasdaq letter dated Oct 28, 2025 confirms company meets $2.5M minimum stockholders' equity requirement.
- Company previously reported negative equity of ($3.87M) in 10-K; received extension until Oct 8, 2025.
- Compliance achieved via share exchange with GridAI Corp, disclosed in Oct 6, 2025 8-K.
- Nasdaq warned that failure to maintain compliance in next periodic report may trigger delisting proceedings.
- Company's stock (ENTO) continues trading on Nasdaq Capital Market without immediate delisting risk.

## SEC filing metadata
- accession: 0001104659-25-104917
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-10-31T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925104917/0001104659-25-104917-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925104917/tm2529898d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-104917
- JSON: https://secwatch.observer/filing/0001104659-25-104917.json
- Plain text: https://secwatch.observer/filing/0001104659-25-104917.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.